Hisamitsu Pharmaceutical Co., Inc. (TYO:4530)
Japan flag Japan · Delayed Price · Currency is JPY
6,040.00
0.00 (0.00%)
Inactive · Last trade price on May 8, 2026

TYO:4530 Cash Flow Statement

Millions JPY. Fiscal year is Mar - Feb.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Net Income
23,65628,68719,18616,11312,956
Depreciation & Amortization
7,0516,3355,1724,9524,321
Loss (Gain) From Sale of Assets
63342852-31955
Loss (Gain) From Sale of Investments
-137-5,019-389257-653
Loss (Gain) on Equity Investments
-728-590-585-424-569
Other Operating Activities
-4,894-3,815-3,954-5,311-119
Change in Accounts Receivable
-9,177-2,525-2,0827802,191
Change in Inventory
-3,482-347-1,628-1,5813,073
Change in Accounts Payable
2,890-2,642686653-2,196
Change in Other Net Operating Assets
2,236-1,661930-2,393140
Operating Cash Flow
17,47818,76518,18812,72719,199
Operating Cash Flow Growth
-6.86%3.17%42.91%-33.71%263.00%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Capital Expenditures
-7,995-13,627-12,924-7,859-3,610
Sale of Property, Plant & Equipment
3111541861,00437
Sale (Purchase) of Intangibles
-55-147-112-49-583
Investment in Securities
-9,12731,18117,109-16,966-8,918
Other Investing Activities
-11-6,773-12
Investing Cash Flow
-16,86617,563-2,512-23,868-13,060

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Long-Term Debt Issued
-1,830---
Total Debt Issued
-1,830---
Short-Term Debt Repaid
-100--4--40
Long-Term Debt Repaid
-1,752-217-66-71-77
Total Debt Repaid
-1,852-217-70-71-117
Net Debt Issued (Repaid)
-1,8521,613-70-71-117
Issuance of Common Stock
1,766----
Repurchase of Common Stock
-12,273-10,554-9,796-7,694-8,043
Common Dividends Paid
-7,593-6,519-6,578-6,719-6,839
Other Financing Activities
-246-390-247-203-190
Financing Cash Flow
-20,198-15,850-16,691-14,687-15,189

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Foreign Exchange Rate Adjustments
-2622,9361,9575,0053,944
Miscellaneous Cash Flow Adjustments
-1--11-
Net Cash Flow
-19,84923,414941-20,822-5,106

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Free Cash Flow
9,4835,1385,2644,86815,589
Free Cash Flow Growth
84.57%-2.39%8.13%-68.77%700.26%
Free Cash Flow Margin
5.82%3.29%3.72%3.79%12.97%
Free Cash Flow Per Share
132.7569.7068.3661.30191.82
Levered Free Cash Flow
1,003-379.38-2,70310,11612,213
Unlevered Free Cash Flow
1,016-365-2,69210,12612,226

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Cash Interest Paid
2125181520
Cash Income Tax Paid
5,0994,2794,0175,333505
Change in Working Capital
-7,533-7,175-2,094-2,5413,208